Strategic Global Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49M Buy
56,834
+37,650
+196% +$3.2M 0.64% 50
2026
Q1
$1.65M Sell
19,184
-270
-1% -$24.2K 0.26% 90
2025
Q4
$1.7M Sell
19,454
-781
-4% -$59.3K 0.26% 92
2025
Q3
$1.16M Buy
20,235
+15
+0.1% +$864 0.18% 107
2025
Q2
$1.19M Buy
20,220
+1,148
+6% +$74.2K 0.19% 102
2025
Q1
$1.4M Sell
19,072
-922
-5% -$76.2K 0.28% 88
2024
Q4
$1.65M Buy
+19,994
New +$1.58M 0.3% 75

Other funds holding GMED

Strategic Global Advisors's GMED Position: Q2 2026 in Review

Strategic Global Advisors increased its Globus Medical (GMED) stake by 196% in Q2 2026, buying an estimated $3.2M and bringing the position to 56,834 shares worth $4.49M. The position accounts for 0.64% of the portfolio, ranked #50.

Strategic Global Advisors first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Strategic Global Advisors held 56,834 shares of Globus Medical worth $4.49M as of Q2 2026.
  • Strategic Global Advisors bought 37,650 Globus Medical shares in Q2 2026, an estimated $3.2M.
  • Globus Medical made up 0.64% of Strategic Global Advisors's portfolio in Q2 2026, its #50 holding.
  • Strategic Global Advisors first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Strategic Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.